AUS
NZ
UK
CA
USA
IND
Healt
ResMed Inc. (ASX: RMD) Faces Share Price Decline on Monday
June 24, 2024 03:28 PM AEST| By Team Kalkine MediaInvestors are witnessing a substantial downturn in ResMed Inc.'s (,ASX: RMD,) share price, which has plummeted by 13% to AU$27.790 in afternoon trading this Monday. The market reaction comes swiftly following the release of pivotal clinical trial res...
Telix Pharmaceuticals (ASX: TLX) Faces Share Price Dip as Nasdaq Listing Plans Axed
June 14, 2024 02:48 PM AEST| By Team Kalkine MediaInvestors in Telix Pharmaceuticals (,ASX: TLX,) are witnessing a downturn in the company's share price today as plans for a Nasdaq listing have been scrapped. After closing at AU$16.46 on Tuesday, shares were halted from trading pending details on th...
CSL (ASX: CSL) targets 13-17% profit growth in FY24
June 05, 2024 03:56 PM AEST| By Team KalkineHighlights,CSL is engaged in the research, development, manufacturing and distribution of biopharmaceutical products and services,In 1HFY24, CSL’s revenue jumped 12% YoY while EBITDA increased by 21% YoY,The Vanguard Group, Inc. has highest stake in...
Two ASX Healthcare Stocks Shine Amidst Market Challenges
June 04, 2024 01:46 PM AEST| By Team Kalkine MediaWhile the broader market grapples with subdued trading conditions, two ASX healthcare shares are defying the trend, posting solid gains on Tuesday. Despite the S&P/ASX 200 Index trading slightly lower, these standout performers are capturing investor...
Telix Pharmaceuticals (ASX: TLX) Soars on Positive Clinical Trial Results and FDA Progress
June 03, 2024 02:12 PM AEST| By Team Kalkine MediaInvestors in Telix Pharmaceuticals Ltd (,ASX: TLX,) are celebrating as the company's share price experiences a surge following positive developments in its clinical trials and regulatory progress. The ASX-listed biopharmaceutical company has witnesse...
Neuren Pharmaceuticals (ASX: NEU) Rollercoaster Week: From Clinical Trial Triumph to Stock Plunge, What Lies Ahead?
May 29, 2024 05:39 PM AEST| By Team Kalkine MediaShares of Neuren Pharmaceuticals (,ASX: NEU,) experienced a sharp decline, falling as much as 10% to AU$20.85, during afternoon trading hours of Wednesday. NEU, a company dedicated to developing therapies for neuro-developmental disorders, found itse...
Fisher & Paykel (ASX: FPH) Reaches New Heights with Strong Earnings Report
May 29, 2024 04:36 PM AEST| By Team Kalkine MediaIt's been a tough day for the S&P/ASX 200 Index, which has dropped 1.30%, pulling it below 7,700 points. However, one healthcare stock is defying the trend and making significant gains on Wednesday. Fisher & Paykel Healthcare Corporation Ltd (,ASX: F...
Pro Medicus (ASX: PME) Shares Surge on $45M Contract Wins
May 28, 2024 04:25 PM AEST| By Team Kalkine MediaShares of Pro Medicus (,ASX: PME,) surged as much as 1.26% to AU$114.67, during afternoon trading hours of Tuesday. The significant uptick in PME shares followed a positive announcement from the healthcare informatics company regarding its U.S. unit,...
Sonic Healthcare (ASX: SHL) Shares Dip Amidst Analyst and Company Forecasts
May 22, 2024 04:22 PM AEST| By Team Kalkine MediaThe stock market can be a volatile place, as evidenced by the recent performance of Sonic Healthcare (,ASX: SHL,). Shares of the healthcare provider experienced a decline of up to 1.21%, reaching AU$24.705, further extending losses from the previous...
Sonic Healthcare (ASX: SHL) Shares Plummet Amid Lowered Profit Forecast
May 21, 2024 04:09 PM AEST| By Team Kalkine MediaShares of Sonic Healthcare Ltd (,ASX: SHL,) experienced a sharp decline on Wednesday, dropping as much as 5.64% to AU$25.11 apiece. If these losses hold, it will mark the worst trading day for the healthcare provider since 20 March 2020. This signifi...
CSL (ASX: CSL) Trials Dynamic Pricing Strategy to Optimise Donor Payments
May 07, 2024 05:13 PM AEST| By Team Kalkine MediaCSL (,ASX: CSL,), the world's leading producer of blood plasma products, is implementing a "dynamic pricing" approach to donor payments as part of its strategy to enhance profit margins amid sustained high supply costs, a senior executive revealed on...
ResMed (ASX: RMD) Share Price Surges Following Strong Quarterly Update
April 29, 2024 04:50 PM AEST| By Team Kalkine MediaThe ResMed Inc. (,ASX: RMD,) share price is on a bullish streak once again, gaining momentum on Monday's trading session, soaring by as much as 3.43% to AU$32.58.,The driving force behind this surge in ResMed's share price can be attributed to the re...
ResMed (ASX: RMD) Shares Surge on Stellar Quarterly Performance
April 26, 2024 03:51 PM AEST| By Team Kalkine MediaResMed (,ASX: RMD,) witnesses a remarkable upswing in its ASX-listed shares, soaring by as much as 8.91% to AU$31.30 apiece, poised to register its most exceptional performance since October 30, 2020, should the gains hold. The surge catapults ResMed...
What drove the surge in these three ASX shares today?
April 23, 2024 03:58 PM AEST| By Team Kalkine MediaIn today's trading session, the Australian stock market witnessed a robust performance, with the S&P/ASX 200 Index continuing its upward trend. As of the latest update (Tue 23 Apr 3:13 PM AEST), the benchmark index surged by 0.37% to reach 7,677.80 p...
What’s driving ResMed (ASX: RMD) share price lower on Thursday?
April 18, 2024 03:45 PM AEST| By Team Kalkine MediaShares of ResMed (,ASX: RMD,) experienced a sharp decline, dropping as much as 4.2% to AU$27.65 apiece on 18 April 2024 at 3:15 PM AEST, marking their steepest decline since 7 August 2023, if losses persist. The downturn came after Eli Lilly (NYSE: L...
Why is Sonic Healthcare (ASX: SHL) gaining attention lately?
April 15, 2024 05:02 PM AEST| By Team Kalkine MediaSonic Healthcare (,ASX: SHL,) emerges as a promising contender for retirement portfolios, showcasing its resilience and growth potential within the S&P/ASX 200 Index (ASX: XJO). As a global leader in pathology services, Sonic operates across various...
Pro Medicus (ASX: PME) shares surge 536% in last five years, up 13% in last three months. Here’s why.
April 12, 2024 05:05 PM AEST| By Team Kalkine MediaFor many investors, the primary goal of engaging in the stock market is to attain remarkable returns. While not every stock delivers exceptional performance, successful investments can yield substantial gains. Consider, for instance, the remarkable a...
Ansell (ASX: ANN) surges as investors embrace acquisition deal and capital raising initiative
April 10, 2024 04:12 PM AEST| By Team Kalkine MediaShares of Australia's leading glove manufacturer, Ansell (,ASX: ANN,), experienced a remarkable surge of approximately 4%, extending gains over the past two trading sessions to an impressive 10.5%. This two-day rally has propelled the stock into posi...
Ansell (ASX: ANN) shares jumped on capital raise of AU$400M
April 09, 2024 03:15 PM AEST| By Team Kalkine MediaAnsell Ltd (,ASX: ANN,) shares re-emerged from a trading halt on Tuesday with a remarkable 5.88% surge, reaching AU$25.30 in afternoon trade (at 2:34PM AEST).,Investor enthusiasm was ignited by a major announcement from the company. Ansell successful...
CSL (ASX: CSL) share price surges following bond issuance announcement
March 27, 2024 02:24 PM AEDT| By Team Kalkine MediaThe share price of CSL Ltd (,ASX: CSL,) is showing notable gains today, with shares of the biotech company in the S&P/ASX 200 Index (ASX: XJO) trading at AU$285.49 in on Wednesday, marking a 1.07% increase from yesterday's closing price of AU$282.47....
Advertise your brand on Kalkine Media